Abstract
Diabetic retinopathy (DR) is by far the most common long-term complication in diabetes, and it is estimated that 95–97% of patients with type 1 diabetes will be affected in time (1,2). Given that blindness is expected to affect 3–8% of type 1 diabetes patients (3,4), it is vital to perform eye screening in order to treat sight-threatening complications prior to irreversible visual loss (5,6).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
